Department of Medicine, Albert Einstein Medical Center, Philadelphia, PA, USA.
Clin Colorectal Cancer. 2010 Jul;9(3):162-7. doi: 10.3816/CCC.2010.n.022.
Colorectal cancer is the fourth most common malignancy in the United States. Its single most important prognostic factor is lymph node involvement. Multiple guidelines recommend sampling a minimum of 12 nodes, to ensure accurate staging and treatment. However, this standard of care is not always achieved. The objective of this study was to identify potential modifiable factors that may explain this inadequacy between the optimal approach and routine practice.
The medical charts of all patients treated for colorectal cancer stages I-III at the Albert Einstein Medical Center from 1999-2007 were reviewed. Associations between multiple surgical and pathologic variables and the presence of >or= 12 lymph nodes in the final pathology report were examined.
In total, 337 patients were included in this study. The mean number of nodes reported was 12.7 (standard deviation, +/- 7.6), and 173 patients (51%) had >or= 12 lymph nodes. Regarding patients' demographic characteristics, 78% were more than 60 years of age; 47.8% were male; and 27% were white, 67% were African American, and 6% were of other ethnic groups. Using a univariate analysis, several variables were statistically associated with the >/= 12 lymph nodes reported: colon length (Pearson r = 0.384; P < .001); thickness of the mesocolon (Pearson r = 0.294; P < .001); size of tumor (Pearson r = 0.154; P = .005); site of tumor (right vs. left, P < .001); type of surgery (right or subtotal colectomy vs. others, P < .001), experience of pathologist (P = .02); pathologist's assistant (P = .006); and experience of surgeon (P < .001). Using a multivariate logistic regression analysis, adjusting for age, sex, and race, colon length (P = .001), type of surgery (odds ratio [OR], 3.37; 95% confidence interval [CI], 2.0-5.6; P < .001), surgeon's experience (OR, 2.33; 95% CI, 1.4-3.9; P = .001), pathologist's experience (OR, 1.9; 95% CI, 1.1-3.2; P = .01), and role of the pathologist's assistant (OR, 2.5; 95% CI, 1.4-4.3; P = .001) remained as significant predictors.
This study showed that multiple factors influence the number of lymph nodes sampled. The roles of the surgeon, the pathologist, and especially the pathologist's assistant comprise significant variables that could be modified with appropriate education.
在美国,结直肠癌是第四大常见恶性肿瘤。其最重要的单一预后因素是淋巴结受累。多项指南建议至少取样 12 个淋巴结,以确保准确分期和治疗。然而,这种标准的护理方法并不总是能够实现。本研究的目的是确定可能解释这种最佳方法与常规实践之间不足的潜在可改变因素。
回顾了 1999 年至 2007 年在爱因斯坦医疗中心接受 I-III 期结直肠癌治疗的所有患者的病历。研究了多个手术和病理变量与最终病理报告中存在>或= 12 个淋巴结之间的关联。
共纳入 337 例患者。报告的平均淋巴结数为 12.7(标准差 +/-7.6),173 例(51%)有>或= 12 个淋巴结。关于患者的人口统计学特征,78%的患者年龄超过 60 岁;47.8%为男性;27%为白人,67%为非裔美国人,6%为其他种族。使用单变量分析,几个变量与报告的>/= 12 个淋巴结具有统计学相关性:结肠长度(皮尔逊 r = 0.384;P<.001);结肠系膜厚度(皮尔逊 r = 0.294;P<.001);肿瘤大小(皮尔逊 r = 0.154;P =.005);肿瘤部位(右侧与左侧,P<.001);手术类型(右结肠或部分结肠切除术与其他手术,P<.001);病理学家的经验(P =.02);病理学家助手(P =.006);外科医生的经验(P<.001)。使用多变量逻辑回归分析,调整年龄、性别和种族因素后,结肠长度(P =.001)、手术类型(比值比 [OR],3.37;95%置信区间 [CI],2.0-5.6;P<.001)、外科医生经验(OR,2.33;95%CI,1.4-3.9;P =.001)、病理学家经验(OR,1.9;95%CI,1.1-3.2;P =.01)和病理学家助手的角色(OR,2.5;95%CI,1.4-4.3;P =.001)仍然是显著的预测因素。
本研究表明,多种因素影响取样的淋巴结数量。外科医生、病理学家,特别是病理学家助手的作用是重要的变量,可以通过适当的教育进行修改。